Conmed (CNMD) Cash from Investing Activities (2010 - 2026)

Conmed has reported Cash from Investing Activities for 17 years, with the latest figure at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 240.25% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at -$13.9 million (changed 0.42% YoY), and the FY2025 full-year result was -$21.0 million, down 60.17% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $4.1 million, up from -$7.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $4.1 million in Q1 2026, with the low at -$148.3 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged -$17.6 million across 5 years, with a median of -$4.9 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 4852.1% — and 2026, when it surged 240.25%.
• Conmed's Cash from Investing Activities stood at -$6.3 million in 2022, then gained by 23.16% to -$4.9 million in 2023, then increased by 16.79% to -$4.0 million in 2024, then slumped by 76.01% to -$7.1 million in 2025, then surged by 157.77% to $4.1 million in 2026.
• The last three Cash from Investing Activities figures came in at $4.1 million (Q1 2026), -$7.1 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.